If you enjoy this content, please share it with a colleague
Civco Medical Solutions
RELATED CONTENT
October 9, 2023 — CIVCO Radiotherapy and Qfix announced the launch of a new brand, CQ Medical. This brand reflects the ...
October 24, 2022 — CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiothe ...
October 24, 2022 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a ...
October 22, 2021 — Blue Wolf Capital Partners LLC, a New York-based private equity firm, today announced it has entered ...
Civco will display its Universal Couchtop ProForm Head & Neck Solution at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago.
The upcoming release of Civco’s Universal Couchtop ProForm Head & Neck Solution will allow proton therapy centers direct access to effectively treat central nervous system (CNS) cancer patients.
Civco Medical Solutions announced a new solution that removes gel from ultrasound procedures. Envision viral barriers allow for 100 percent gel-free procedures.
Civco Medical Solutions will present Envision, the next generation of ultrasound probe covers and scan pads, at the 2018 Radiological Society of North America (RSNA) annual meeting, Nov. 25-30 in Chicago.
CIVCO Medical Solutions, a provider of comprehensive motion management solutions for radiation oncology, exhibited its latest innovations and product offering to attendees of the American Association of Physicists in Medicine (AAPM) 58th Annual Meeting in Washington, D.C., in July.
Civco Medical Solutions announced that it has acquired PCI Medical, a market leader in high-level disinfection products for ultrasound transducers. The acquisition equips Civco with a portfolio of hardware and consumables for cost-effective infection control compliance in the ultrasound transducer reprocessing market.